Data Foundry

Drug recalls 2024

Pregabalin Capsules 50mg — Class III drug recall D-0541-2024

Ongoing recall by Rising Pharma Holding, Inc., reported 2024-06-12, distributed nationwide. Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP),

Recall numberD-0541-2024
Product typeDrug
ClassificationClass III
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmRising Pharma Holding, Inc., East Brunswick, NJ, United States
Recall initiated2024-05-16
Classified2024-06-04
Reported by FDA2024-06-12
DistributedNationwide (US)
NDC64980-0410, 64980-0410-01, 64980-0410-09, 64980-0410-10, 64980-0411, 64980-0411-01, 64980-0411-09, 64980-0411-10, 64980-0412, 64980-0412-01, 64980-0412-09, 64980-0412-10, 64980-0413, 64980-0413-01, 64980-0413-09, 64980-0413-10, 64980-0414, 64980-0414-01, 64980-0414-09, 64980-0414-10, 64980-0415, 64980-0415-01, 64980-0415-09, 64980-0415-10, 64980-0416 and 7 more
Lot numbers23132611
Expiration dates2026-07-31

Product

Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 64980-411-10

Reason for recall

Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0541-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.